Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.

PloS one - 1 Jan 2018

Rosemary Audu, Chika Onwuamah, Jonathan Okpokwu, Godwin Imade, Georgina Odaibo, Azuka Okwuraiwe, Zaidat Musa, Philippe Chebu, Oliver Ezechi, Oche Agbaji, David Olaleye, Jay Samuel, Ibrahim Dalhatu, Mukhtar Ahmed, Joshua DeVos, Chunfu Yang, Elliot Raizes, Beth Chaplin, Phyllis Kanki, Emmanuel Idigbe

Abstract excerpt

BACKGROUND: ATCC HIV-1 drug resistance test kit was designed to detect HIV-1 drug resistance (HIVDR) mutations in the protease and reverse transcriptase genes for all HIV-1 group M subtypes and circulating recombinant forms. The test has been validated for both plasma and dried blood spot specimen types with viral load (VL) of ≥1000 copies/ml. We performed an in-country assessment on the kit to determine the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Genotyping Techniques

Share to Random Allocation

Share to Reagent Kits, Diagnostic

Source

Open in PubMed Open full text

Identifiers

PMID: 29953436
DOI: 10.1371/journal.pone.0198246
PMCID: PMC6023177

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotyping performance evaluation of commercially available HIV-1 drug resistance test.PMID 29953436Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.Semantic proximity Read ↗

HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System.Semantic proximity Read ↗

Update on antiretroviral drug resistance testing: combining laboratory technology with patient care.Semantic proximity Read ↗

Comparison of Plasma, Dried Blood Spots, and Peripheral Blood Mononuclear Cells as Biosamples for HIV-1 Genotypic Drug Resistance in a Tertiary Care Center.Semantic proximity Read ↗

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.Semantic proximity Read ↗

An HIV-1 integrase genotype assay for the detection of drug resistance mutations.Semantic proximity Read ↗

HIV type-1 drug resistance testing on dried blood spots is feasible and reliable in patients who fail antiretroviral therapy in rural Tanzania.Semantic proximity Read ↗

Performance characteristics of a modified HIV-1 drug resistance genotyping method for use in resource-limited settingsSemantic proximity Read ↗

HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited settingSemantic proximity Read ↗

Performance characteristics of the TRUGENE HIV-1 Genotyping Kit and the Opengene DNA Sequencing System.Semantic proximity Read ↗

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.